PetMed Express Statistics
Total Valuation
PetMed Express has a market cap or net worth of $96.23 million. The enterprise value is $43.68 million.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PetMed Express has 20.63 million shares outstanding. The number of shares has increased by 0.78% in one year.
| Current Share Class | 20.63M |
| Shares Outstanding | 20.63M |
| Shares Change (YoY) | +0.78% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 4.27% |
| Owned by Institutions (%) | 39.80% |
| Float | 16.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.36 |
| Forward PS | 0.73 |
| PB Ratio | 0.98 |
| P/TBV Ratio | 1.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 27.52 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.17 |
| EV / EBITDA | 7.49 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.45 |
| Quick Ratio | 1.10 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.18 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -0.92% and return on invested capital (ROIC) is -0.12%.
| Return on Equity (ROE) | -0.92% |
| Return on Assets (ROA) | -0.09% |
| Return on Capital (ROIC) | -0.12% |
| Revenue Per Employee | $903,634 |
| Profits Per Employee | -$3,355 |
| Employee Count | 287 |
| Asset Turnover | 1.70 |
| Inventory Turnover | 11.75 |
Taxes
In the past 12 months, PetMed Express has paid $475,000 in taxes.
| Income Tax | 475,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.90% in the last 52 weeks. The beta is 0.68, so PetMed Express's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | -39.90% |
| 50-Day Moving Average | 4.11 |
| 200-Day Moving Average | 4.19 |
| Relative Strength Index (RSI) | 51.79 |
| Average Volume (20 Days) | 371,296 |
Short Selling Information
The latest short interest is 1.70 million, so 8.23% of the outstanding shares have been sold short.
| Short Interest | 1.70M |
| Short Previous Month | 2.01M |
| Short % of Shares Out | 8.23% |
| Short % of Float | 10.05% |
| Short Ratio (days to cover) | 9.34 |
Income Statement
In the last 12 months, PetMed Express had revenue of $259.34 million and -$963,000 in losses. Loss per share was -$0.05.
| Revenue | 259.34M |
| Gross Profit | 71.34M |
| Operating Income | -211,000 |
| Pretax Income | -133,000 |
| Net Income | -963,000 |
| EBITDA | 5.83M |
| EBIT | -211,000 |
| Loss Per Share | -$0.05 |
Full Income StatementBalance Sheet
The company has $52.05 million in cash and $1.21 million in debt, giving a net cash position of $50.83 million or $2.46 per share.
| Cash & Cash Equivalents | 52.05M |
| Total Debt | 1.21M |
| Net Cash | 50.83M |
| Net Cash Per Share | $2.46 |
| Equity (Book Value) | 96.43M |
| Book Value Per Share | 4.67 |
| Working Capital | 21.95M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $3.40 million and capital expenditures -$4.32 million, giving a free cash flow of -$918,000.
| Operating Cash Flow | 3.40M |
| Capital Expenditures | -4.32M |
| Free Cash Flow | -918,000 |
| FCF Per Share | -$0.04 |
Full Cash Flow StatementMargins
Gross margin is 27.51%, with operating and profit margins of -0.08% and -0.37%.
| Gross Margin | 27.51% |
| Operating Margin | -0.08% |
| Pretax Margin | -0.19% |
| Profit Margin | -0.37% |
| EBITDA Margin | 2.25% |
| EBIT Margin | -0.08% |
| FCF Margin | -3.25% |
Dividends & Yields
PetMed Express does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.78% |
| Shareholder Yield | -0.78% |
| Earnings Yield | -1.03% |
| FCF Yield | -0.98% |
Dividend DetailsAnalyst Forecast
The average price target for PetMed Express is $3.50, which is -24.95% lower than the current price. The consensus rating is "Sell".
| Price Target | $3.50 |
| Price Target Difference | -24.95% |
| Analyst Consensus | Sell |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on March 4, 1999. It was a forward split with a ratio of 3:1.
| Last Split Date | Mar 4, 1999 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
PetMed Express has an Altman Z-Score of 4.05 and a Piotroski F-Score of 3.
| Altman Z-Score | 4.05 |
| Piotroski F-Score | 3 |